Shots: HitGen to receive upfront and milestones from Kymera. The companies collaborated to identify small molecule leads against targets of interest to Kymera HitGen will leverage its platform technology based […]readmore
Tags : HitGen
Shots: HitGen to receive upfront & milestones from Almirall to develop novel small molecules for Almirall’s target The focus of the collaboration is to utilize HitGen’s technology based on DNA-encoded […]readmore
Shots: HitGen to receive upfront & milestones and will utilize its DNA-encoded library design technology to develop therapies for Sun Pharma’s SPARC targets The focus of the collaboration is to […]readmore